Clinical trials
Image clinical trials
Below are recruiting image clinical trials, each written for real people, not researchers. We’re tracking 2,186 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06572475Recruiting
New MRI contrast for brain tumors
This trial uses a new type of MRI contrast dye (USPIO) to get clearer images of certain slow-growing brain tumors (vestibular schwannomas and low-grade gliomas). The goal is to see if this dye helps doctors better understand and treat these tumors.
Salford, Greater ManchesterAges 16–100 - NCT06572605RecruitingPhase 1/Phase 2
Radiation plus talquetamab for myeloma outside the bone
This trial tests combining radiation therapy with a targeted drug called talquetamab for multiple myeloma that has formed tumors outside the bone (extramedullary disease). It aims to see if this combination can shrink or control these tumors and improve outcomes.
Duarte, CaliforniaAges 18 years+ - NCT06579547Recruiting
Testing MRI instead of CT for joint imaging
This study tests if a new, radiation-free MRI method can replace standard CT scans for checking joint problems like arthritis. You would get both an MRI and a CT scan, and researchers compare the results to see if the MRI works just as well without radiation.
ZurichAges 18 years+ - NCT06581744Recruiting
New PET scan for detecting primary aldosteronism
This trial uses a special PET scan to find a condition called primary aldosteronism (too much aldosterone hormone). It may help people who need surgery or who are hard to diagnose with standard tests.
Dalian, LiaoningAges 18 years+ - NCT06582472Recruiting
Early eye changes and diabetes trial
This study looks at early damage to the retina (the back of the eye) in people with type 2 diabetes, even before vision problems start. It aims to find new ways to detect and treat diabetic eye disease early.
Milan, Italy/milanAges 40–80 - NCT06584123Recruiting
Molecular imaging of pituitary adenoma with 18F-FET PET
This study uses a special PET scan (18F-FET) to get clearer images of pituitary adenomas (non-cancerous growths at the base of the brain). It is for people who have already had one type of PET scan and can help doctors understand the tumor better without invasive procedures.
Cambridge, CambridgeshireAges 18–100 - NCT06584357Recruiting
Digital and blood markers linked to brain scans in older adults
This study is looking for older adults (60–90) who are either cognitively normal, have mild cognitive impairment (MCI), or have mild-to-moderate Alzheimer's dementia. It aims to see how digital tests and blood-based markers relate to brain scans (amyloid and tau PET). You will need a study partner, undergo MRI and PET scans, and give blood samples.
Atlantis, FloridaAges 60–90 - NCT06584266Recruiting
Cardiac imaging registry for atrial fibrillation
This study collects data from heart imaging tests (TEE) in people with atrial fibrillation or atrial flutter. It aims to better understand how these imaging results relate to treatment decisions and outcomes.
BrnoAges 18 years+ - NCT06586047RecruitingEarly Phase 1
PSMA PET scan for triple-negative breast cancer
This trial uses a special PET scan to see if PSMA, a protein on some cancer cells, can help detect triple-negative breast cancer that has spread to other parts of the body.
Iowa City, IowaAges 18–90 - NCT06590948Recruiting
Using ultrasound features to classify liver nodules
This trial looks at whether special features seen on contrast-enhanced ultrasound can help doctors better classify liver nodules using a system called LI-RADS. It’s for people at high risk for liver cancer who have recent imaging and clear tissue diagnosis.
Hangzhou, ZhejiangAges 18 years+ - NCT06592820Recruiting
Ultrasound stiffness test for fatty liver disease
This study uses a special ultrasound technique, called shear wave elastography, to measure liver stiffness during an endoscopic ultrasound (EUS) procedure. It aims to see how well this new method detects liver scarring (fibrosis) in people with fatty liver disease, compared to standard tests like FibroScan and liver biopsy.
Boston, MassachusettsAges 18 years+ - NCT06596460Recruiting
Imaging study after TAVI valve replacement
This study collects extra imaging data from 40 people who are already scheduled for a routine TAVI procedure to replace a narrowed aortic heart valve. The goal is to better understand the valve's structure and function using scans.
London, EnglandAges 18 years+ - NCT07213219Recruiting
PET-MRI scan for Parkinson's with sleep behavior disorder
This trial uses a combined PET and MRI scan to study the brain's reward system in people with Parkinson's disease who also have REM sleep behavior disorder (RBD). It aims to understand how the brain changes and may help guide future treatments.
Clermont-FerrandAges 45–80 - NCT07679048Recruiting
Eye focus test after close-up screen time
This study measures how quickly your eyes refocus after looking at close-up images or videos for a while. It may help researchers understand eye strain from screens.
Rochester, New YorkAges 18–35 - NCT07689656RecruitingPhase 1/Phase 2
PET imaging study for prostate cancer using a new tracer
This trial tests a new radioactive tracer called ELI421 to see how well it works for PET imaging in people with prostate cancer. It may help doctors find cancer more clearly.
Wuhan, HubeiAges 18–80 - NCT06723457RecruitingPhase 2
Epcoritamab and lenalidomide for immunodeficiency-related lymphoma
This trial tests a combination of two drugs, epcoritamab and lenalidomide, for patients with a rare type of large B-cell lymphoma linked to a weakened immune system. It is for people whose lymphoma did not improve or returned after standard treatments, and who cannot get CAR-T therapy.
Chicago, IllinoisAges 18 years+ - NCT07657312RecruitingPhase 2
Infliximab to prevent side effects during myeloma treatment
This trial tests if infliximab, a drug that calms the immune system, can prevent cytokine release syndrome (a serious side effect) when patients receive teclistamab or talquetamab for multiple myeloma that has returned or not responded to treatment.
Columbus, OhioAges 18 years+ - NCT07237932Enrolling by invitation
Adenomyosis diagnosis study for women considering hysterectomy
This study looks at how well different methods (clinical exams, imaging, and tissue analysis after surgery) can diagnose adenomyosis. It is for women who have heavy bleeding and pain, have completed their families, and have decided to have a hysterectomy.
Kafr ash ShaykhAges 35–55 - NCT06601231Recruiting
Better liver cancer screening with GAAD score and imaging
This study looks at whether adding a blood test (the GAAD score) to standard imaging can better detect liver cancer at an early stage in people with chronic liver disease. It may help you if you have cirrhosis or certain types of liver scarring.
Rotterdam, CAAges 18 years+ - NCT06602037Recruiting
ImmunoPET imaging for pancreatic cancer
This trial tests a new imaging method called ImmunoPET to see if it can help detect pancreatic cancer more clearly. If you have or might have pancreatic cancer, this study could help doctors understand your condition better.
ShanghaiAges 18–70 - NCT06603454Recruiting
Chest CT before aortic valve replacement surgery
This study looks at whether a CT scan of the chest before aortic valve replacement surgery (with or without bypass) can help doctors plan the procedure better. It is for people with severe aortic valve stenosis who are already scheduled for surgery.
Nieuwegein, UtrechtAges 18 years+ - NCT06604260RecruitingPhase 2
PET scan to measure inflammation in Crohn's and colitis
This trial uses a special PET scan called FAPi-PET to look for inflammation and scarring in the gut. It may help doctors better understand your condition and guide treatment.
Amsterdam, North HollandAges 18 years+ - NCT06606808RecruitingPhase 1/Phase 2
Imaging risankizumab in inflammatory bowel disease
This trial tests a new imaging method using a special dye (risankizumab-800CW) to see how risankizumab, a medicine for inflammatory bowel disease, works in the bowel. The goal is to better understand the medicine's effects and help doctors tailor treatments.
GroningenAges 18 years+ - NCT06610019Recruiting
Heart imaging study using MRI
This study uses heart MRI scans to learn more about cardiovascular health in adults. If you are 18 or older and have been referred for a heart MRI at Montefiore, you may be able to join.
The Bronx, New YorkAges 18 years+
Hear when a new Image trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for image?
- Yes. Clin2 currently lists 2,186 recruiting image studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a image trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a image trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.